Your browser doesn't support javascript.
loading
Moving Beyond Quality-Adjusted Life-Years in Elderly Care: How Can Multicriteria Decision Analysis Complement Cost-Effectiveness Analysis in Local-Level Decision Making.
Hoedemakers, Maaike; Tsiachristas, Apostolos; Rutten-van Mölken, Maureen.
Afiliación
  • Hoedemakers M; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. Electronic address: hoedemakers@eshpm.eur.nl.
  • Tsiachristas A; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, England, UK.
  • Rutten-van Mölken M; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Value Health ; 25(10): 1717-1725, 2022 10.
Article en En | MEDLINE | ID: mdl-35623974
OBJECTIVES: This study aimed to investigate how multicriteria decision analysis (MCDA) could complement cost-effectiveness analysis (CEA) to support investment decisions in elderly care at local level. METHODS: We used an integrated elderly care program in The Netherlands as a case study to demonstrate the application of both methods. In a 12-month quasi-experimental study (n = 384), data on the following outcome measures were collected: quality-adjusted life-years (CEA) and physical functioning, psychological well-being, social relationships and participation, enjoyment of life, resilience, person centeredness, continuity of care, and costs (MCDA). We performed regression analysis on inversed probability weighted data and controlled for potential confounders to obtain a double robust estimate of the outcomes. Probabilistic sensitivity analyses determined uncertainty for both methods. RESULTS: The integrated elderly care program was not likely (ie, 36%) to be cost-effective according to the CEA (incremental cost-effectiveness ratios: €88 249 from a societal perspective) using the conventional Dutch willingness-to-pay threshold (ie, €50 000). The MCDA demonstrated that informal caregivers and professionals slightly preferred the intervention over usual care, driven by enjoyment of life and person centeredness. Patients did not prefer either the intervention or usual care, whereas payers and policy makers slightly preferred usual care, mainly due to higher costs of the intervention. CONCLUSIONS: MCDA could provide local-level decision makers with a broader measurement of effectiveness by including outcomes beyond health and longevity and the preferences of multiple stakeholders. This additional information could foster the acceptability and implementability of cost-effective innovations in elderly care.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antígeno Carcinoembrionario / Técnicas de Apoyo para la Decisión Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antígeno Carcinoembrionario / Técnicas de Apoyo para la Decisión Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article